Malignant Respiratory System Neoplasm — Trials

Malignant Respiratory System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

11,128 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,650
Recruiting: 1,432
Ph III recruiting: 179
Growth YoY: +7%
Industry share: 37%
Top sponsor: AstraZeneca
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,492)

clinicaltrialsPublishedShowing 251–300 of 559 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00579514	Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients	active not recruiting	N/A	21,081	Memorial Sloan Kettering Cancer CenterOTHER	1	Apr 7, 2026	clinicaltrials
NCT06079970	Confocal Laser Endomicroscopy VERification(CLEVER)	recruiting	N/A	208	Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)OTHER	5	Apr 7, 2026